98 related articles for article (PubMed ID: 24673720)
1. Specific polyclonal F(ab')2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice.
Herbreteau CH; Jacquot F; Rith S; Vacher L; Nguyen L; Carbonnelle C; Lotteau V; Jolivet M; Raoul H; Buchy P; Saluzzo JF
Immunotherapy; 2014; 6(6):699-708. PubMed ID: 24673720
[TBL] [Abstract][Full Text] [Related]
2. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
3. Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab')2 against highly pathogenic avian influenza H5N1 in mice.
Zhao Z; Yan F; Chen Z; Luo D; Duan Y; Yang P; Li Z; Peng D; Liu X; Wang X
Int Immunopharmacol; 2011 Dec; 11(12):2000-6. PubMed ID: 21906698
[TBL] [Abstract][Full Text] [Related]
4. Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')₂ fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study.
Bal C; Herbreteau CH; Buchy P; Rith S; Zaid M; Kristanto W; Han V; Reynaud C; Granjard P; Lépine B; Durand C; Tambyah PA
Lancet Infect Dis; 2015 Mar; 15(3):285-92. PubMed ID: 25662592
[TBL] [Abstract][Full Text] [Related]
5. Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab')2.
Zhao Z; Fan C; Duan Y; Zhang L; Li M; Yang X; Li R; Yang P; Wang X
Int Immunopharmacol; 2014 Nov; 23(1):134-8. PubMed ID: 25192652
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
Simmons CP; Bernasconi NL; Suguitan AL; Mills K; Ward JM; Chau NV; Hien TT; Sallusto F; Ha do Q; Farrar J; de Jong MD; Lanzavecchia A; Subbarao K
PLoS Med; 2007 May; 4(5):e178. PubMed ID: 17535101
[TBL] [Abstract][Full Text] [Related]
7. Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice.
Harada Y; Ninomiya-Mori A; Takahashi Y; Shirakura M; Kishida N; Kageyama T; Tada Y; Tashiro M; Odagiri T
Vaccine; 2011 Oct; 29(46):8330-7. PubMed ID: 21911027
[TBL] [Abstract][Full Text] [Related]
8. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.
Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N
J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063
[TBL] [Abstract][Full Text] [Related]
9. [Effects of immunoglobulin on murine myocarditis caused by influenza A virus: experimental study].
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
J Cardiol; 2005 Jun; 45(6):247-55. PubMed ID: 15991608
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterization and pathogenicity assessment of highly pathogenic H5N1 avian influenza viruses isolated from migratory wild birds in 2011, South Korea.
Kwon HI; Song MS; Pascua PN; Baek YH; Lee JH; Hong SP; Rho JB; Kim JK; Poo H; Kim CJ; Choi YK
Virus Res; 2011 Sep; 160(1-2):305-15. PubMed ID: 21782862
[TBL] [Abstract][Full Text] [Related]
11. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.
Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W
Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection.
Itoh Y; Yoshida R; Shichinohe S; Higuchi M; Ishigaki H; Nakayama M; Pham VL; Ishida H; Kitano M; Arikata M; Kitagawa N; Mitsuishi Y; Ogasawara K; Tsuchiya H; Hiono T; Okamatsu M; Sakoda Y; Kida H; Ito M; Quynh Mai L; Kawaoka Y; Miyamoto H; Ishijima M; Igarashi M; Suzuki Y; Takada A
PLoS Pathog; 2014 Jun; 10(6):e1004192. PubMed ID: 24945244
[TBL] [Abstract][Full Text] [Related]
13. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
14. DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin.
Wang G; Zhou F; Buchy P; Zuo T; Hu H; Liu J; Song Y; Ding H; Tsai C; Chen Z; Zhang L; Deubel V; Zhou P
J Infect Dis; 2014 Mar; 209(5):676-85. PubMed ID: 23911711
[TBL] [Abstract][Full Text] [Related]
15. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
[TBL] [Abstract][Full Text] [Related]
16. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library.
Pitaksajjakul P; Lekcharoensuk P; Upragarin N; Barbas CF; Ibrahim MS; Ikuta K; Ramasoota P
Biochem Biophys Res Commun; 2010 May; 395(4):496-501. PubMed ID: 20382115
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of wood ducks to H5N1 highly pathogenic avian influenza virus.
Brown JD; Stallknecht DE; Valeika S; Swayne DE
J Wildl Dis; 2007 Oct; 43(4):660-7. PubMed ID: 17984261
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.
Herbreteau CH; Denizot M; Lowther S; Riddell S; Frazer L; Haining J; Arkinstall R; Payne J; Harper J; Johnson D; Pasquier A; Middleton D; Saluzzo JF
Immunotherapy; 2016 Sep; 8(9):1021-32. PubMed ID: 27380317
[TBL] [Abstract][Full Text] [Related]
19. An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses.
Shoji Y; Chichester JA; Palmer GA; Farrance CE; Stevens R; Stewart M; Goldschmidt L; Deyde V; Gubareva L; Klimov A; Mett V; Yusibov V
Hum Vaccin; 2011; 7 Suppl():199-204. PubMed ID: 21922687
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals.
Isoda N; Sakoda Y; Kishida N; Bai GR; Matsuda K; Umemura T; Kida H
Arch Virol; 2006 Jul; 151(7):1267-79. PubMed ID: 16502281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
